RATIONALE: Pharmacological manipulations of the type 1 cannabinoid receptor (CB1) suggest a role for CB1 in morphine-induced antinociception, but studies utilizing CB1 knockout (KO) mice do not support this conclusion. Since studies using CB1 KO mice to study morphine's antinociceptive effects have only examined thermal nociception, this study examines these interactions in models that employ a chemical stimulus. OBJECTIVES: To determine whether the findings obtained with thermal pain models extend to other models, the effects of morphine on acetic acid-induced writhing were examined in CB1 KO and wildtype (WT) mice. Behaviors that decrease in response to acid injection, feeding and wheel running, were also examined, and investigations were carried out in the thermal hotplate assay. The CB1 antagonist SR141716A was also examined in these assays. RESULTS: Morphine completely blocked acid-induced writhing (1.0-10.0 mg/kg) and increased response latencies in the hotplate (10.0-32.0 mg/kg) in both genotypes. Morphine (3.2 mg/kg) significantly attenuated the suppression of wheel running but did not completely prevent this effect in either genotype. Morphine did not alter pain-suppressed feeding. In each of these assays, morphine's effects were not altered in CB1 KO mice compared with WT mice; however, SR141716A attenuated morphine's effects in C57BL/6 mice. CONCLUSIONS: The effects of morphine do not differ in CB1 KO and WT mice in preclinical pain models using thermal and chemical stimuli. Since SR141716A did attenuate the effects of morphine, it is possible that CB1 KO mice undergo developmental changes that mask the role of CB1 receptors in morphine's antinociceptive effects.
RATIONALE: Pharmacological manipulations of the type 1 cannabinoid receptor (CB1) suggest a role for CB1 in morphine-induced antinociception, but studies utilizing CB1 knockout (KO) mice do not support this conclusion. Since studies using CB1 KO mice to study morphine's antinociceptive effects have only examined thermal nociception, this study examines these interactions in models that employ a chemical stimulus. OBJECTIVES: To determine whether the findings obtained with thermal pain models extend to other models, the effects of morphine on acetic acid-induced writhing were examined in CB1 KO and wildtype (WT) mice. Behaviors that decrease in response to acid injection, feeding and wheel running, were also examined, and investigations were carried out in the thermal hotplate assay. The CB1 antagonist SR141716A was also examined in these assays. RESULTS:Morphine completely blocked acid-induced writhing (1.0-10.0 mg/kg) and increased response latencies in the hotplate (10.0-32.0 mg/kg) in both genotypes. Morphine (3.2 mg/kg) significantly attenuated the suppression of wheel running but did not completely prevent this effect in either genotype. Morphine did not alter pain-suppressed feeding. In each of these assays, morphine's effects were not altered in CB1 KO mice compared with WT mice; however, SR141716A attenuated morphine's effects in C57BL/6 mice. CONCLUSIONS: The effects of morphine do not differ in CB1 KO and WT mice in preclinical pain models using thermal and chemical stimuli. Since SR141716A did attenuate the effects of morphine, it is possible that CB1 KO mice undergo developmental changes that mask the role of CB1 receptors in morphine's antinociceptive effects.
Authors: B F Cravatt; K Demarest; M P Patricelli; M H Bracey; D K Giang; B R Martin; A H Lichtman Journal: Proc Natl Acad Sci U S A Date: 2001-07-24 Impact factor: 11.205
Authors: Mehmet Ates; May Hamza; Kay Seidel; Carolin E Kotalla; Catherine Ledent; Hans Gühring Journal: Eur J Neurosci Date: 2003-02 Impact factor: 3.386
Authors: Kathryn A Seely; Lisa K Brents; Lirit N Franks; Maheswari Rajasekaran; Sarah M Zimmerman; William E Fantegrossi; Paul L Prather Journal: Neuropharmacology Date: 2012-07-04 Impact factor: 5.250
Authors: Lakeisha A Lewter; Janet L Fisher; Justin N Siemian; Kashi Reddy Methuku; Michael M Poe; James M Cook; Jun-Xu Li Journal: ACS Chem Neurosci Date: 2017-02-13 Impact factor: 4.418
Authors: Laurence L Miller; Mitchell J Picker; Michael D Umberger; Karl T Schmidt; Linda A Dykstra Journal: J Pharmacol Exp Ther Date: 2012-04-18 Impact factor: 4.030
Authors: Ram Kandasamy; Todd M Hillhouse; Kathryn E Livingston; Kelsey E Kochan; Claire Meurice; Shainnel O Eans; Ming-Hua Li; Andrew D White; Bernard P Roques; Jay P McLaughlin; Susan L Ingram; Neil T Burford; Andrew Alt; John R Traynor Journal: Proc Natl Acad Sci U S A Date: 2021-04-20 Impact factor: 11.205
Authors: S Stevens Negus; Bradley Neddenriep; Ahmad A Altarifi; F Ivy Carroll; Michael D Leitl; Laurence L Miller Journal: Pain Date: 2015-06 Impact factor: 7.926